{
    "organizations": [],
    "uuid": "bfa9ef53348d2d9ed19a290bf12efffc9379a042",
    "author": "",
    "url": "https://www.reuters.com/article/brief-ptc-therapeutics-announces-present/brief-ptc-therapeutics-announces-presentation-of-preliminary-data-from-part-1dose-finding-portion-of-ongoing-firefish-clinical-trial-idUSASC09X7H",
    "ord_in_thread": 0,
    "title": "BRIEF-PTC Therapeutics announces presentation of preliminary data from Part 1,dose finding portion, of ongoing FIREFISH clinical trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " PTC Therapeutics Inc:\n* PRELIMINARY CLINICAL DATA FROM FIREFISH TRIAL IN TYPE 1 SMA PATIENTS PRESENTED AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING\n* DATA FROM PART 1 DEMONSTRATED RG7916 HAS BEEN WELL TOLERATED AT ALL DOSE LEVELS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-25T04:52:00.000+03:00",
    "crawled": "2018-04-25T05:10:51.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "ptc",
        "therapeutic",
        "inc",
        "preliminary",
        "clinical",
        "data",
        "firefish",
        "trial",
        "type",
        "sma",
        "patient",
        "presented",
        "american",
        "academy",
        "neurology",
        "annual",
        "meeting",
        "data",
        "part",
        "demonstrated",
        "rg7916",
        "well",
        "tolerated",
        "dose",
        "level",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}